We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
Mississippi's Board of Nursing, Board of Pharmacy, and State Board of Medical Licensure released a statement on peptides.
2027 is coming for compounding. Get to DC first
The FDA still doesn’t have draft guidance for manufacturers, importers, and distributors of animal-derived thyroid products.
If your legislator is on one of the congressional committees that have the greatest influence on compounding legislation, we need you at CCH.
We're giving a thumbs-up to a bill that’s actively advancing in the state.
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
